Jurgen Eckel
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action.
Journal: JHEP reports : innovation in hepatology
Published: July 04, 2025
Positive allosteric GABAA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitro.
Journal: Frontiers in physiology
Published: November 23, 2022
Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus.
Journal: Molecular metabolism
Published: June 13, 2022
Positive allosteric γ-aminobutyric acid type A receptor modulation prevents lipotoxicity-induced injury in hepatocytes in vitro.
Journal: Diabetes, obesity & metabolism
Published: February 16, 2022
NDUFB6 Polymorphism Is Associated With Physical Activity-Mediated Metabolic Changes in Type 2 Diabetes.
Journal: Frontiers in endocrinology
Published: April 11, 2021
Intestinal microbiota and host metabolism - A complex relationship.
Journal: Acta physiologica (Oxford, England)
Published: February 27, 2021
Cannabinoid Receptors in Metabolic Regulation and Diabetes.
Journal: Physiology (Bethesda, Md.)
Published: February 17, 2021
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Journal: Frontiers in pharmacology
Published: June 05, 2020
Integrins-Mediators of cellular adhesion or more?
Journal: Acta physiologica (Oxford, England)
Published: April 25, 2020
DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Journal: American journal of physiology. Endocrinology and metabolism
Published: January 01, 2020
Last Updated: 09/26/2026